• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌肿瘤位置对预后的影响及其变异性原因。

Prognostic impact and reasons for variability by tumor location in gastric cancer.

机构信息

Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310022, Zhejiang Province, China.

School of Medicine, Zhejiang University, Hangzhou 310058, Zhejiang Province, China.

出版信息

World J Gastroenterol. 2024 Nov 28;30(44):4709-4724. doi: 10.3748/wjg.v30.i44.4709.

DOI:10.3748/wjg.v30.i44.4709
PMID:39610778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11580611/
Abstract

BACKGROUND

Gastric cancer (GC) is a highly prevalent gastrointestinal tract tumor. Several trials have demonstrated that the location of GC can affect patient prognosis. However, the factors determining tumor location remain unclear.

AIM

To investigate the tumor location of patients, we went on to study the influencing factors that lead to changes in the location of GC.

METHODS

A retrospective evaluation was carried out on 3287 patients who underwent gastrectomy for GC in Zhejiang Cancer Hospital. The patients were followed up post-diagnosis and post-gastrectomy. The clinicopathological variables and overall survival of the patients were recorded. By analyzing the location of GC, the tumor location was divided into four categories: "Upper", "middle", "lower", and "total". Statistical software was utilized to analyze the relationship of each variable with the location of GC.

RESULTS

A total of 3287 patients were included in this study. The clinicopathological indices of gender, age, serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen (CA19-9) and CA72-4 levels, were significantly associated with tumor location in patients with GC. In addition, there was a strong correlation between GC location and the prognosis of postoperative patients. Specifically, patients with "lower" and "middle" GC demonstrated a better prognosis than those with tumors in other categories.

CONCLUSION

The five clinicopathological indices of gender, age, CEA, CA19-9 and CA72-4 levels exhibit varying degrees of influence on the tumor location. The tumor location correlates with patient prognosis following surgery.

摘要

背景

胃癌(GC)是一种高发的胃肠道肿瘤。多项试验表明,GC 的位置会影响患者的预后。然而,决定肿瘤位置的因素仍不清楚。

目的

为了研究患者的肿瘤位置,我们进一步研究了导致 GC 位置变化的影响因素。

方法

对在浙江省肿瘤医院接受胃癌胃切除术的 3287 例患者进行回顾性评估。对患者进行诊断后和胃切除术后随访。记录患者的临床病理变量和总生存期。通过分析 GC 的位置,将肿瘤位置分为四个类别:“上部”、“中部”、“下部”和“全部”。使用统计软件分析每个变量与 GC 位置的关系。

结果

本研究共纳入 3287 例患者。GC 患者的性别、年龄、血清癌胚抗原(CEA)、糖类抗原(CA19-9)和 CA72-4 水平等临床病理指标与肿瘤位置显著相关。此外,GC 位置与术后患者的预后有很强的相关性。具体来说,“下部”和“中部”GC 的患者预后比其他部位肿瘤的患者要好。

结论

性别、年龄、CEA、CA19-9 和 CA72-4 水平这五个临床病理指标对肿瘤位置有不同程度的影响。肿瘤位置与术后患者的预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0926/11580611/b2840cce5a3f/WJG-30-4709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0926/11580611/54ce773052a8/WJG-30-4709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0926/11580611/dabf5f0e5ad1/WJG-30-4709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0926/11580611/2553b40e302d/WJG-30-4709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0926/11580611/1af8b43ccc91/WJG-30-4709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0926/11580611/b2840cce5a3f/WJG-30-4709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0926/11580611/54ce773052a8/WJG-30-4709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0926/11580611/dabf5f0e5ad1/WJG-30-4709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0926/11580611/2553b40e302d/WJG-30-4709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0926/11580611/1af8b43ccc91/WJG-30-4709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0926/11580611/b2840cce5a3f/WJG-30-4709-g005.jpg

相似文献

1
Prognostic impact and reasons for variability by tumor location in gastric cancer.胃癌肿瘤位置对预后的影响及其变异性原因。
World J Gastroenterol. 2024 Nov 28;30(44):4709-4724. doi: 10.3748/wjg.v30.i44.4709.
2
Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.胃癌患者肿瘤标志物的临床评估与预后评价。
Int J Biol Markers. 2013 Jun 28;28(2):192-200. doi: 10.5301/jbm.5000023.
3
Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.胃癌患者中CA72-4与CEA和CA19-9相比的临床意义及预后价值
Dis Markers. 2000;16(3-4):105-10. doi: 10.1155/2000/595492.
4
Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer.血清癌胚抗原、糖类抗原19-9及糖类抗原72-4在胃癌患者中的临床意义及诊断价值
Oncotarget. 2016 Aug 2;7(31):49565-49573. doi: 10.18632/oncotarget.10391.
5
The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.癌胚抗原、CA19.9和CA72.4的血清及胃液水平在胃癌患者中的作用
J Cancer Res Clin Oncol. 1998;124(8):450-5. doi: 10.1007/s004320050198.
6
Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.用于上消化道癌患者诊断、复发监测及预后评估的肿瘤标志物。
Asian Pac J Cancer Prev. 2014;15(23):10267-72. doi: 10.7314/apjcp.2014.15.23.10267.
7
Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.血清癌胚抗原、糖类抗原72-4、糖类抗原19-9及肿瘤特异性生长因子联合检测在胃癌诊断中的价值
Asian Pac J Cancer Prev. 2015;16(9):3867-70. doi: 10.7314/apjcp.2015.16.9.3867.
8
Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.术前血清中五种肿瘤标志物(癌胚抗原、CA19-9、甲胎蛋白、CA72-4和CA125)水平在胃癌中的预后价值
Hepatogastroenterology. 2014 May;61(131):863-9.
9
CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.CA72-4联合癌胚抗原(CEA)、糖类抗原125(CA125)和糖类抗原19-9(CA19-9)可提高胃癌早期诊断的敏感性。
Clin Chim Acta. 2014 Nov 1;437:183-6. doi: 10.1016/j.cca.2014.07.034. Epub 2014 Jul 30.
10
An Alternative Method for Screening Gastric Cancer Based on Serum Levels of CEA, CA19-9, and CA72-4.一种基于血清癌胚抗原(CEA)、糖类抗原19-9(CA19-9)和糖类抗原72-4(CA72-4)水平筛查胃癌的替代方法。
J Gastrointest Cancer. 2018 Mar;49(1):57-62. doi: 10.1007/s12029-016-9912-7.

引用本文的文献

1
Integrating tumor location into artificial intelligence-based prognostic models in cancer.将肿瘤位置纳入基于人工智能的癌症预后模型。
World J Clin Oncol. 2025 Aug 24;16(8):109934. doi: 10.5306/wjco.v16.i8.109934.
2
Impact of Treatment Modalities on Locally Advanced Gastric Cancer-Real-World Data.治疗方式对局部晚期胃癌的影响——真实世界数据
Curr Oncol. 2025 Aug 16;32(8):463. doi: 10.3390/curroncol32080463.
3
Evaluating log odds of positive lymph nodes as a prognostic tool in differentiated gastric cancer: A retrospective study.
评估阳性淋巴结的对数几率作为分化型胃癌的预后工具:一项回顾性研究。
World J Gastroenterol. 2025 Jun 7;31(21):107029. doi: 10.3748/wjg.v31.i21.107029.
4
The prognostic impact of body mass index on patients with gastric adenocarcinoma and mucinous adenocarcinoma: a retrospective cohort study.体重指数对胃腺癌和黏液腺癌患者的预后影响:一项回顾性队列研究。
J Gastrointest Oncol. 2025 Feb 28;16(1):41-52. doi: 10.21037/jgo-24-593. Epub 2025 Feb 26.